PQ 24
51 Deputy Jim O’Keeffe asked the Minister for Health and Children her views on whether there are potential savings of up to €350 million a year through the use of branded generic drugs throughout the health service; if so, the way these savings might best be achieved; and the obstacles that are in place, whether legislative or otherwise, in this regard. [13023/09]
Introduced
31 March 2009
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
31 March 2009
Summary
51 Deputy Jim O’Keeffe asked the Minister for Health and Children her views on whether there are potential savings of up to €350 million a year through the use of branded generic drugs throughout the health service; if so, the way these savings might best be achieved; and the obstacles that are in place, whether legislative or otherwise, in this regard. [13023/09]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products.
Medicinal Products.
xml · EN · 31 March 2009
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2009-03-31/24/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2009-03-31/pq_24